FluidAI Medical
Developer and deployer of data-driven surgical care technologies that combine continuous biochemical and physiologic sensing, electronic health record integration, and machine learning. Focus areas include real-time monitoring of postoperative drain fluid, predictive models and expert systems for postoperative complications, in-house device manufacturing, and clinical evidence generation for gastrointestinal and general surgery.
Industries
Nr. of Employees
small (1-50)
Products
Real-time surgical drain monitoring device
Inline device that attaches to surgical drains to continuously measure biochemical parameters (pH, conductivity, temperature) for early detection of complications.
Postoperative clinical risk prediction platform
Platform that consolidates EHR and physiologic data, runs predictive models and surgical expert systems, prioritizes patients, and delivers transparent risk drivers to clinical teams.
Real-time surgical drain monitoring device
Inline device that attaches to surgical drains to continuously measure biochemical parameters (pH, conductivity, temperature) for early detection of complications.
Postoperative clinical risk prediction platform
Platform that consolidates EHR and physiologic data, runs predictive models and surgical expert systems, prioritizes patients, and delivers transparent risk drivers to clinical teams.
Services
Tailored machine learning model development, retrospective data analysis, and deployment aligned to institutional workflows and patient populations.
Centralization of disparate clinical and device data, building ETL/ELT pipelines, data modeling, dashboards, and self-service analytics.
Phased implementation services including discovery, co-design, technical setup, privacy approvals, clinical pilots, onboarding, and scale-up support.
Multilingual patient support with conversational assistants, wearable integration, symptom flagging, and clinician dashboards to support remote monitoring and education.
Real-time capture of clinical events to generate compliant discharge summaries and structured clinical documentation to support coding and billing.
Tailored machine learning model development, retrospective data analysis, and deployment aligned to institutional workflows and patient populations.
Centralization of disparate clinical and device data, building ETL/ELT pipelines, data modeling, dashboards, and self-service analytics.
Phased implementation services including discovery, co-design, technical setup, privacy approvals, clinical pilots, onboarding, and scale-up support.
Multilingual patient support with conversational assistants, wearable integration, symptom flagging, and clinician dashboards to support remote monitoring and education.
Real-time capture of clinical events to generate compliant discharge summaries and structured clinical documentation to support coding and billing.
Expertise Areas
- Real-time physiological and biochemical monitoring
- Clinical predictive modeling and surgical expert systems
- Electronic health record integration
- Medical device manufacturing and quality systems
Key Technologies
- Nanosensor-based biochemical sensing (pH, conductivity, temperature)
- Continuous physiologic and biosensor data capture
- Machine learning for clinical risk prediction
- EHR interfacing and clinical data integration
News & Updates
Announcement that the company's drain-monitoring device received FDA 510(k) clearance (device-specific availability may vary by jurisdiction).
Secured a $2-million Government of Canada investment to support global commercialization of AI-driven postoperative care technology.
Company announced an acquisition deal with Emmetros Limited.
Feasibility study examining changes in drain fluid pH and conductivity as early predictors of anastomotic leaks.
Study examining how early detection of anastomotic leaks affects outcomes and healthcare costs by comparing data before and after platform deployment.
Study evaluating safety, usability, and effectiveness of at-home monitoring using the platform, and correlation with standard laboratory and clinical assessments.
Announcement that the company's drain-monitoring device received FDA 510(k) clearance (device-specific availability may vary by jurisdiction).
Secured a $2-million Government of Canada investment to support global commercialization of AI-driven postoperative care technology.
Company announced an acquisition deal with Emmetros Limited.
Feasibility study examining changes in drain fluid pH and conductivity as early predictors of anastomotic leaks.
Study examining how early detection of anastomotic leaks affects outcomes and healthcare costs by comparing data before and after platform deployment.
Study evaluating safety, usability, and effectiveness of at-home monitoring using the platform, and correlation with standard laboratory and clinical assessments.